Literature DB >> 22948868

Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing.

Imran Sulemankhil1, Jorge Gabriel Ganopolsky, Christopher Anthony Dieni, Andrei Florin Dan, Mitchell Lawrence Jones, Satya Prakash.   

Abstract

The use of percutaneous medical devices often results in nosocomial infections. Attachment of microorganisms to the surfaces of these medical devices triggers biofilm formation, which presents significant complications to the health of a patient and may lead to septicemia, thromboembolism, or endocarditis if not correctly treated. Although several antimicrobials are commonly used for prevention of biofilm formation, they have limited efficacy against formed biofilms. In this study, we report the use of an enzymatic, gaseous nitric oxide (gNO)-releasing dressing for the prevention and treatment of Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa biofilms. Results show that the bactericidal activity against biofilms of the test strains was dependent on time and rate of gNO release from the dressing. Following 6 h of treatment, gNO-releasing dressings significantly inhibited the growth of test strains relative to vehicle control dressings, demonstrating eradication of bacterial concentrations of up to 10(5) CFU/cm(2). Complete cell death was observed for both prevention of biofilm formation and treatment of 24-h-grown biofilms after 6 h of treatment with the gNO-releasing dressings. Further, gNO-releasing dressings were more efficient against formed biofilms than other antimicrobial agents currently used. These results demonstrate that the gNO-releasing dressing can produce sufficient levels of gNO over a therapeutically relevant duration for maximal bactericidal effects against virulent bacterial strains known to cause nosocomial infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948868      PMCID: PMC3497171          DOI: 10.1128/AAC.01173-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

Review 1.  Catheter-related infections: diagnosis and intravascular treatment.

Authors:  E Bouza; A Burillo; P Muñoz
Journal:  Clin Microbiol Infect       Date:  2002-05       Impact factor: 8.067

Review 2.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  Am J Infect Control       Date:  2002-12       Impact factor: 2.918

3.  A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis.

Authors:  Mitchell Lawrence Jones; Jorge G Ganopolsky; Alain Labbé; Satya Prakash
Journal:  Appl Microbiol Biotechnol       Date:  2010-03-19       Impact factor: 4.813

4.  Argyria: permanent skin discoloration following protracted colloid silver ingestion.

Authors:  Ruth Thompson; Vanessa Elliott; Adrian Mondry
Journal:  BMJ Case Rep       Date:  2009-02-16

Review 5.  Nitric oxide release: part II. Therapeutic applications.

Authors:  Alexis W Carpenter; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2012-02-24       Impact factor: 54.564

Review 6.  Reducing implant-related infections: active release strategies.

Authors:  Evan M Hetrick; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2006-05-05       Impact factor: 54.564

7.  Dilute povidone-iodine solutions inhibit human skin fibroblast growth.

Authors:  Arthur K Balin; Loretta Pratt
Journal:  Dermatol Surg       Date:  2002-03       Impact factor: 3.398

Review 8.  Nitric oxide function in the skin.

Authors:  M-M Cals-Grierson; A D Ormerod
Journal:  Nitric Oxide       Date:  2004-06       Impact factor: 4.427

9.  The etiology and persistence of cryptic bacterial infections: a hypothesis.

Authors:  J W Costerton
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

10.  Characterization and comparison of biofilm development by pathogenic and commensal isolates of Histophilus somni.

Authors:  Indra Sandal; Wenzhou Hong; W Edward Swords; Thomas J Inzana
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

View more
  16 in total

Review 1.  Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?

Authors:  Kamal Dua; Shakti D Shukla; Rakesh K Tekade; Philip M Hansbro
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

2.  Design, Synthesis, and Antibacterial Activity of a Multivalent Polycationic Calix[4]arene-NO Photodonor Conjugate.

Authors:  Grazia M L Consoli; Ivana Di Bari; Anna R Blanco; Antonia Nostro; Manuela D'Arrigo; Venerando Pistarà; Salvatore Sortino
Journal:  ACS Med Chem Lett       Date:  2017-07-05       Impact factor: 4.345

3.  Deciphering nitric oxide stress in bacteria with quantitative modeling.

Authors:  Jonathan L Robinson; Kristin J Adolfsen; Mark P Brynildsen
Journal:  Curr Opin Microbiol       Date:  2014-06-29       Impact factor: 7.934

Review 4.  Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.

Authors:  Sinosh Skariyachan; Vaishnavi Sneha Sridhar; Swathi Packirisamy; Supreetha Toplar Kumargowda; Sneha Basavaraj Challapilli
Journal:  Folia Microbiol (Praha)       Date:  2018-01-19       Impact factor: 2.099

5.  Persister formation in Escherichia coli can be inhibited by treatment with nitric oxide.

Authors:  Mehmet A Orman; Mark P Brynildsen
Journal:  Free Radic Biol Med       Date:  2016-02-02       Impact factor: 7.376

6.  A kinetic platform to determine the fate of nitric oxide in Escherichia coli.

Authors:  Jonathan L Robinson; Mark P Brynildsen
Journal:  PLoS Comput Biol       Date:  2013-05-02       Impact factor: 4.475

7.  Rhodomyrtone modulates innate immune responses of THP-1 monocytes to assist in clearing methicillin-resistant Staphylococcus aureus.

Authors:  Sutthirat Srisuwan; Pongsri Tongtawe; Potjanee Srimanote; Supayang Piyawan Voravuthikunchai
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

8.  Model-driven identification of dosing regimens that maximize the antimicrobial activity of nitric oxide.

Authors:  Jonathan L Robinson; Richard V Miller; Mark P Brynildsen
Journal:  Metab Eng Commun       Date:  2014-09-01

9.  Diversity, Bacterial Symbionts and Antibacterial Potential of Gut-Associated Fungi Isolated from the Pantala flavescens Larvae in China.

Authors:  Ming-Wei Shao; Yi-Hui Lu; Shuang Miao; Yun Zhang; Ting-Ting Chen; Ying-Lao Zhang
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics.

Authors:  Yun Yang; Haibo Li; Hongwu Sun; Li Gong; Ling Guo; Yun Shi; Changzhi Cai; Hao Gu; Zhen Song; Liuyang Yang; Yanan Tong; Chao Wei; Quanming Zou; Hao Zeng
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.